XML 39 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
 12 Months Ended 144 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2013
Cash flows used in operating activities:      
Net loss $ (6,939) $ (4,320) $ (74,933)
Adjustments to reconcile net loss to net cash used in operating activities:      
Gain on patent rights assignment     (2,000)
Gain on bargain purchase     (25,282)
Depreciation and amortization 26 43 1,806
Non-cash interest expense     211
Share-based compensation 283 306 2,871
Issuance of warrants for lease termination     377
Accretion of liabilities     152
Impairment of property and equipment     125
Impairment of in-process research and development     6,000
Write-off of deferred tax liability     (2,281)
Gain on marketable securities available for sale     (263)
(Gain) loss from disposal of property and equipment     83
Other, net     267
Change in operating assets and liabilities (net of amounts acquired):      
Other current assets 130 278 2,950
Other assets 14 80 7,340
Accounts payable 532 (195) (1,593)
Accrued expenses and other liabilities 681 (237) (18,540)
Deferred rent (15) (33) 1
Net cash used in operating activities (5,288) (4,078) (102,709)
Cash flows provided by investing activities:      
Cash received from merger     30,392
Payment of deferred transaction costs     (1,186)
Purchase of property and equipment (32)   (1,911)
Proceeds from sale of marketable securities     15,369
Proceeds from sale of property and equipment     358
Proceeds from patent rights assignment     2,000
Net cash (used in) provided by investing activities (32)   45,022
Cash flows provided by financing activities:      
Proceeds from issuance of convertible notes payable and related warrants for common stock 19,300   10,841
Proceeds from issuance of bank note payable     4,000
Proceeds from stock subject to repurchase     38
Proceeds from the issuance of preferred stock 20,000   52,316
Proceeds from the issuance of common stock 1,741 1,528 15,850
Repayment of principal on bank note payable     (4,000)
Repayment of principal on convertible notes payables     (105)
Repayment of principal on vendor finance agreement (174) (134) (454)
Net cash provided by financing activities 19,156 1,055 74,443
Net (decrease) increase in cash and cash equivalents 13,836 (3,023) 16,756
Cash and cash equivalents, beginning of period 2,920 5,943  
Cash and cash equivalents, end of period 16,756 2,920 16,756
Supplemental cash flow information:      
Interest paid 3 3 118
Supplemental disclosure of noncash investing and financing transactions:      
Accrued interest on notes payable converted to equity     163
Warrant issued in connection with credit facility     111
Accrued deferred transaction costs     482
Preferred Stock
      
Cash flows provided by financing activities:      
Payment of offering costs (2,083)   (2,329)
Common Stock
      
Cash flows provided by financing activities:      
Payment of offering costs $ (328) $ (339) $ (1,714)